Patent Assignment
Reel/Frame 045599/0642
Assignment of Assignor's Interest
Recorded: 2018-04-20
Pages: 6
Assignor
OHLSTEIN, ELIOT
Executed: 2016-02-16
Assignee
VELICEPT THERAPEUTICS, INC.
101 LINDEENWOOD DRIVE, SUITE 400, MALVERN, PENNSYLVANIA, 19355
Covered Properties
(2)
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Application:
15/951,953 →
Publication:
US 2019/0083433
Compositions and Methods of Using Modified Release Solabegron for Lower Urinary Tract Symptoms
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2018
From: STEVENS, RAYMOND E.
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045599/0754 →
Assignment of Assignor's Interest
Apr 20, 2018
From: WILKINS, H. JEFFREY
To: NST CONSULTING, LLC
Reel/Frame 045599/0918 →
Assignment of Assignor's Interest
Apr 20, 2018
From: NST CONSULTING, LLC
To: VELICEPT THERAPEUTICS, INC.
Reel/Frame 045600/0171 →
Security Interest
Oct 7, 2019
From: VELICEPT THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050642/0074 →
Assignment of Assignor's Interest
May 19, 2021
From: VELICEPT (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC; VELICEPT THERAPEUTICS, INC.
To: B3AR THERAPEUTICS, INC.
Reel/Frame 056285/0273 →